<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> is a frequent cause of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related <z:hpo ids='HP_0011420'>death</z:hpo> in men and women </plain></SENT>
<SENT sid="1" pm="."><plain>miRNAs (microRNAs) are endogenous small non-coding <z:chebi fb="40" ids="33697">RNAs</z:chebi> that regulate gene expression negatively at the post-transcriptional level </plain></SENT>
<SENT sid="2" pm="."><plain>In the present study we investigated the possible role of microRNAs in the development of <z:chebi fb="14" ids="53218">MDR</z:chebi> (multidrug resistance) in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> cells </plain></SENT>
<SENT sid="3" pm="."><plain>We analysed miRNA expression levels between <z:chebi fb="14" ids="53218">MDR</z:chebi> colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> cell line HCT116/L-OHP cells and their parent cell line HCT116 using a miRNA microarray </plain></SENT>
<SENT sid="4" pm="."><plain>miR-297 showed lower expression in HCT116/L-OHP cells compared with its parental cells </plain></SENT>
<SENT sid="5" pm="."><plain>MRP-2 (<z:chebi fb="14" ids="53218">MDR</z:chebi>-associated protein 2) is an important <z:chebi fb="14" ids="53218">MDR</z:chebi> protein in <z:chebi fb="240" ids="33364,33400">platinum</z:chebi>-drug-resistance cells and is a predicted target of miR-297 </plain></SENT>
<SENT sid="6" pm="."><plain>Additionally miR-297 was down-regulated in a panel of human colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> tissues and negatively correlated with expression levels of MRP-2 </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, we found that ectopic expression of miR-297 in <z:chebi fb="14" ids="53218">MDR</z:chebi> colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> cells reduced MRP-2 protein level and sensitized these cells to anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> drugs in vitro and in vivo </plain></SENT>
<SENT sid="8" pm="."><plain>Taken together, our findings suggest that miR-297 could play a role in the development of <z:chebi fb="14" ids="53218">MDR</z:chebi> in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> cells, at least in part by modulation of MRP-2 </plain></SENT>
</text></document>